Team StartupCity

• CrisprBits raises $3 Million in a Pre-Series A round led by Spectrum Impact
• Funding to boost commercial rollout of its PathCrisp diagnostics platform
• Startup to expand global footprint and build CRISPR and AI-driven engineering tools

Bengaluru-based biotechnology startup CrisprBits has raised $3 million in a Pre-Series A round, pushing its valuation to $12 million. The round was led by Spectrum Impact, the family office of Rajendra Gogri, Chairman and Managing Director of Aarti Industries. Existing investor Vijay Alreja Family Office (VJ Technologies Group) also joined the round, along with new investors from the promoter family of HBL Engineering. The company previously secured capital from its founders, VJ Technologies Group, and C-CAMP.

With the fresh investment, CrisprBits aims to scale the commercial rollout of its PathCrisp molecular diagnostics platform and expand manufacturing capacity for human health, food safety, and animal health tests. The company is also working on a CRISPR-powered strain engineering platform, beginning with applications in biofuel production.

Founded by Vijay Chandru, Sunil Arora, Rajeev Kohli, Bharat Jobanputra, and Aditya Sarda, CrisprBits operates a 7,300 sq ft CRISPR R&D and prototype facility in Bengaluru. It runs three core platforms including PathCrisp for molecular diagnostics, EdiCrisp for gene editing and strain engineering, and CurieCrisp for preclinical and rare disease therapeutics.

Also Read: Riverline AI Raises $825,000 to Accelerate Fintech Expansion

Over the next six months, the startup plans to take its diagnostics products to global markets, with a focus on Africa and Latin America. It will also strengthen its manufacturing operations and build an AI-augmented strain engineering platform to support sustainability-focused innovations.